Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces... Corrections & amendments Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Retraction to: Nature Medicine Michela Garofalo, Giulia Romano, Gianpiero Di Leva, https://doi.org/10.1038/nm.2577, published Gerard Nuovo, Young-Jun Jeon, Apollinaire Ngankeu, Jin Sun, Francesca Lovat, online 11 December 2011. Hansjuerg Alder, Gerolama Condorelli, Jeffrey A. Engelman, Mayumi Ono, Jin Kyung Rho, Luciano Cascione, Stefano Volinia, Kenneth P. Nephew and https://doi.org/10.1038/s41591-022-02044-2 Carlo M. Croce Published online: 4 October 2022 Check for updates The editors are retracting this article owing to issues that have come to our attention regarding the integrity of several images in the study. In November 2021, Nature Medicine was informed by The Ohio State University that a forensic analysis concluded that data in the shCtr/shEGFR panel (lines miR-30c to miR-101) and the shCtr/shMET panel (lines miR-548d to miR-203) of Figure 1b were identical. Further internal review of all the data in the study by the journal confirmed this finding and identified other instances in which images appear to be used in multiple figure panels, including the beta actin panels in Figure 1a, 1g and 1i, and the GAPDH panels in Figures 4b and 6g. The authors were contacted http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Medicine Springer Journals

Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

Abstract

Corrections & amendments Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Retraction to: Nature Medicine Michela Garofalo, Giulia Romano, Gianpiero Di Leva, https://doi.org/10.1038/nm.2577, published Gerard Nuovo, Young-Jun Jeon, Apollinaire Ngankeu, Jin Sun, Francesca Lovat, online 11 December 2011. Hansjuerg Alder, Gerolama Condorelli, Jeffrey A. Engelman, Mayumi Ono, Jin Kyung Rho,...
Loading next page...
 
/lp/springer-journals/retraction-note-egfr-and-met-receptor-tyrosine-kinase-altered-microrna-cgG8mwCkBs

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © Springer Nature America, Inc. 2022
ISSN
1078-8956
eISSN
1546-170X
DOI
10.1038/s41591-022-02044-2
Publisher site
See Article on Publisher Site

Abstract

Corrections & amendments Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Retraction to: Nature Medicine Michela Garofalo, Giulia Romano, Gianpiero Di Leva, https://doi.org/10.1038/nm.2577, published Gerard Nuovo, Young-Jun Jeon, Apollinaire Ngankeu, Jin Sun, Francesca Lovat, online 11 December 2011. Hansjuerg Alder, Gerolama Condorelli, Jeffrey A. Engelman, Mayumi Ono, Jin Kyung Rho, Luciano Cascione, Stefano Volinia, Kenneth P. Nephew and https://doi.org/10.1038/s41591-022-02044-2 Carlo M. Croce Published online: 4 October 2022 Check for updates The editors are retracting this article owing to issues that have come to our attention regarding the integrity of several images in the study. In November 2021, Nature Medicine was informed by The Ohio State University that a forensic analysis concluded that data in the shCtr/shEGFR panel (lines miR-30c to miR-101) and the shCtr/shMET panel (lines miR-548d to miR-203) of Figure 1b were identical. Further internal review of all the data in the study by the journal confirmed this finding and identified other instances in which images appear to be used in multiple figure panels, including the beta actin panels in Figure 1a, 1g and 1i, and the GAPDH panels in Figures 4b and 6g. The authors were contacted

Journal

Nature MedicineSpringer Journals

Published: Nov 1, 2022

There are no references for this article.